Clinical trial
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian…
NCT00031954 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00031954 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer |
| Official title | A Phase II Study Of Paclitaxel, Carboplatin And Gemcitabine In Previously Untreated Patients With Epithelial Ovarian Carcinoma FIGO Stage IIB-IV |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, gemcitabine hydrochloride, paclitaxel |
| Enrollment | 105 |
| Start date | Aug 1, 2001 |
| Primary completion | Apr 1, 2004 |
| First posted | Jul 1, 2003 |
| Last update posted | Dec 23, 2015 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: